Navigation Links
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Date:9/8/2008

New Senior Management Appointments Strengthen Executive Team

FREMONT, Calif., Sept. 8 /PRNewswire/ -- Zosano Pharma, Inc., a privately held pharmaceutical company developing a novel transdermal delivery technology, today announced that Gail Schulze has joined the company as chair and CEO. The company also announced several recent appointments to the Zosano leadership team, including Don Brown, chief operating officer and president; John M. Vuko, executive vice president and chief financial officer; Beth Anne Piper, M.D., vice president, clinical development; and Stephen Worsley, vice president, business development.

In her new role of chair and CEO, Ms. Schulze will spearhead Zosano's strategic and operational initiatives to advance the company's novel therapeutic programs, including its lead product Zosano PTH Patch, a proprietary transdermal patch formulation of parathyroid hormone (PTH) for the treatment of established osteoporosis.

"Gail brings a tremendous track record of executive leadership to Zosano, and her depth of experience will be a key asset as the company advances its product pipeline and pursues strategic partnerships to leverage the potential of Zosano's innovative transdermal delivery technology," said Jim Barrett, Ph.D., formerly chairman of Zosano's board of directors and a general partner at New Enterprise Associates, Inc. (NEA).

In addition to her role at Zosano, Ms. Schulze has held numerous board positions and is currently a director of Cerus Corporation (Nasdaq: CERS). She was previously CEO of YM Biosciences US and president, YM Biosciences, Inc. Prior to joining YM Biosciences, she was president, CEO and director of Eximias Pharmaceutical Corporation. She formerly served as COO an
'/>"/>

SOURCE Zosano Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. GeoPharma, Inc. Receives FDA Approval to Manufacture and Distribute Carprofen
2. Novo Nordisk Inc. Announces Exclusive Agreement With Sciele Pharma, Inc. to Market Prandin(R)
3. China Biopharma, Inc. Announces New Plan of Operation
4. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
5. CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
6. SCOLR Pharma, Inc. Schedules Second Quarter 2008 Financial Results Conference Call for August 7, 2008 at 11:30 A.M. Eastern
7. SCOLR Pharma, Inc. Reports Second Quarter 2008 Financial Results
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...e/ -- Stemline Therapeutics, Inc. today announced ...argeting agents, SL-401 and SL-501, in both in vi...ukemia (CML) have been selected for poster present...merican Society of Hematology (ASH), to be held in...ill be presented by Stemline,s collaborators at Th...
(Date:12/3/2009)...wire-FirstCall/ -- VIA Pharmaceuticals, Inc. (Nasd...e development of compounds for the treatment of ca...d that it has completed the last patient visit in ..., The FDG-PET trial enrolled 52 patients and wa...ncluding Massachusetts General Hospital, Mount Sin...
(Date:12/3/2009)...Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D.,...otechnology Co. Ltd.,( http://www.beikebiotech.com...oot Care in New Delhi, India, November 22, 2009. B...enerative medicine company. , The confere...(IPA), aimed,to help podiatrists and researchers w...
(Date:12/2/2009)...wire/ -- Reportlinker.com announces that a new mar... ,, Drug Discovery Technologies - A Global Upd...ttp://www.reportlinker.com/p0164246/Drug-Discovery...Opportunities.html ,, Drug discovery has becom...eutical company,s business strategy. There are a n...
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
...s market average selling price for dental implants...r European countries, WALTHAM, Mass., Nov. 19 Mi...Marketrack service offers insight into an importan...age price of dental,implants sold in Italy is near...ermany, France, and the UK. The presence of many m...
...Md., Nov. 16 Spherix Incorporated,(Nasdaq: SPEX ...f $3.1,million ($0.22 per share) and $7.1 million ...ended September 30, 2007, respectively. These loss...ds of 2006 due to increased,expenditures related t...e,as a treatment for type 2 diabetes. The Company ...
...lease is available in German . , Many scientists...mple methods for the production of tiny particles ...special regular patterns in two or three dimension...miniature objects have countless applications in m...eneration of artificial tissues to improved data s...
Other Biology Technology:Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market 2Spherix Reports 3rd Quarter Earnings 2Two-faced miniatures 2
(Date:12/4/2009)...idely used by physicians and scientists to study b...rs. However, it has remained largely unknown wheth...f what is happening inside the brain. Scientists a...ics in Tbingen, Germany, have now found a crucial ...in to that measured with EEG. These findings will ...
(Date:12/3/2009)...ewswire-FirstCall/ -- BIO-key International, Inc. ...ublic safety and finger-based biometric identifica...hareholders at a Special Shareholder Meeting held ...cement Division to Interact911 Mobile Systems Inc.... 1.2% were opposed. ,, (Logo: http://www.newsc...
(Date:12/3/2009)...els that repels grime and dirt? Expanded battery s...el Aviv University research, just published in Na...sembling peptides at the nano-scale level that cou... a few years. , Operating in the range of 100 na...en smaller, graduate student Lihi Adler-Abramovich...
Breaking Biology News(10 mins):How to read brain activity? 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 2BIO-key(R) Shareholders Overwhelmingly Approve Sale of Law Enforcement Division 3A window that washes itself? 2Chiropractic Helps Strengthen Immune System and Prevent Sickness 56979 1Chiropractic Helps Strengthen Immune System and Prevent Sickness 56979 2New sources of biofuel to take pressure off traditional crops 9893 1University of Hawaii at Manoa CRCH scientists report adulthood body size associated with cancer risk 56975 1University of Hawaii at Manoa CRCH scientists report adulthood body size associated with cancer risk 56975 2
...ITHERSBURG, Md.Researchers at the Commerce Departm...gy (NIST) and Cornell University have capitalized ... at the nanometer (billionth of a meter) level and...irst-ever nanoscale fluidic (nanofluidic) device w...cribed in a paper published online today in the jo...
...RESS RELEASE, 31 March 2009] Researchers at the S...I) have constructed a mathematical activity model ...ease the understanding of the capacity of the work...he brain interact. One of the findings they have m...brain,s neuronal network that restricts the number...
...potential treatment for HIV may one day help peopl...y, suggests new research published tomorrow in The...nkeys with the simian form of HIV were able to red...levels, by treating the monkeys with a molecule ca.... , Simian Immunodeficiency Virus (SIV) is very s...
Other Biology News:NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 2NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 3NIST-Cornell team builds world's first nanofluidic device with complex 3-D surfaces 4Computer simulations explain the limitations of working memory 2Potential new HIV drug may help patients not responding to treatment 2Potential new HIV drug may help patients not responding to treatment 3
Anti-alpha1-Antitrypsin Monoclonal Antibody, Unconjugated from CHEMICON
Mouse LIGHT / TNFSF14, Unconjugated from R&D Systems
Ral Immunoblot Assay Kit from Upstate
BL21 Star (DE3) One Shot Chemically Competent E. coli from Invitrogen
Biology Products: